Brodalumab

• Autore principale: Murat Borlu (Autore)
• Natura: Libro
• Pubblicazione: Galenos Publishing House, 2022-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Brodalumab is a human monoclonal antibody that inhibits interleukin-17 (IL-17) pathway by binding to IL-17 receptor. In clinical trials, a PASI75 response has been achieved in 82-84% of the patients at week 12. It was shown to be effective also in generalized pustular and erythrodermic psoriasis. As...